Protective effects of TRH and its analogues in chemical and genetic models of seizures

Polish Journal of Pharmacology

Volumn 49, Issue 5, 1997, Pages 373-378

  Przewłocka, Barbara ^a   ŁAbuz, Dominika ^a   Mika, Joanna ^a   Lipkowski, A ^a   Van Luijtelaar, Gilles ^c   Coenen, Anton ^c   Lasoń, Władysław ^b  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Absence epilepsy; Penetrazole seizures; Seizures; Thyrotropin releasing hormone; WAG Rij rats

Indexed keywords

POSATIRELIN; PROTIRELIN; PROTIRELIN DERIVATIVE;

ANIMAL MODEL; ARTICLE; DOSE RESPONSE; EXCITABILITY; GENETIC MODEL; MALE; NONHUMAN; RAT; SEIZURE; SEIZURE THRESHOLD; TONIC SEIZURE;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; CONVULSANTS; MALE; PENTYLENETETRAZOLE; RATS; RATS, WISTAR; SEIZURES; THYROTROPIN-RELEASING HORMONE;

EID: 1842298211     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Bajorek J. G., Lee R. J., Lomax R: Neuropeptides: a role as endogenous mediators or modulators of epileptic phenomena. Ann. Neurol., 1984, 16, 31-38.
2. Bennett G. W., Sharp T., Brazell M., Marsden C. A.: TRH and catecholamine neurotransmitter release in the central nervous system. In: Thyrotropin-Releasing Hormone. Eds. Griffiths E. C., Bennett G. W., Raven Press, New York, 1983, 253-269.
3. Bhargava H. N., Yousif D. J., Matwyshyn G. A.: Interactions of thyrotropin releasing hormone, its metabolites and analogues with endogenous and exogenous opiates. Gen. Pharmacol., 1983, 14, 565-570.
4. Buzsáki G.: The thalamic clock: emergent network properties. Neuroscience, 1991, 41, 351-364,
5. Chepurnova N. E., Kossova G. V., Abbasova C., Kumar P. C., Chepurnov S. A., Ashmarin I. P.: Thyrotropin releasing hormone (TRH) in ultra low doses de- creases severity of seizures in rats. Neuropeptides, 1994, 26 Suppl. 1, 52.
6. Coenen A. M. L., Drinkenburg W. H. I. M., Inoue M., Van Luijtelaar E. L. J. M.: Genetic models of absence epilepsy with an emphasis on the WAG/Rij strain. Epilepsy Res., 1992, 12, 75-86.
7. Dolva L. O., Riddervold F., Thorsen R. K.: Side effects of thyrotropin releasing hormone. Brit. Med. J., 1983, 287, 532.
8. 3H-dopamine from slices of rat nucleus accumbens in vitro. Brit. J. Pharmacol., 1979, 67, 323-326.
9. Kreider M. S., Wolfinger B. L., Winokur A.: Systemic administration of kainic acid produces elevations in TRH in cat central nervous system. Regul. Peptides, 1990, 28, 83-93.
10. Kubek M. J., Knoblach S. M., Sharif N. A., Burt D. R., Buterbaugh G. G., Fuson K. S.: Thyrotropin-releasing hormone gene expression and receptors are differentially modified in limbic foci by seizures. Ann. Neurol., 1993, 33, 70-76.
11. Lasoń W., Przewłocka B., van Luijtelaar E. L. J. M., Coenen A. M. L., Przewłocki R.: Effects of μ and δ opioid receptor agonists and antagonists on absence epilepsy in WAG/Rij rats. Neuropharmacology, 1994, 33, 161-166.
12. Maeda T., Tanimoto K.: Epileptic seizures induced by thyrotropin releasing hormone. Lancet, 1981, 1, 1058-1059.
13. Matsumoto A., Kumagai T., Takeuchi T., Miyazaki S., Watanabe K.: Clinical effects of thyrotropin-releasing hormone for severe epilepsy in childhood: a comparative study with ACTH therapy. Epilepsia, 1987, 28, 49-55.
14. Morley J. E.: Extrahypothalamic thyrotropin releasing hormone (TRH) - its distribution and its functions. Life Sci., 1979, 25, 1539-1550.
15. Nemeroff C. B., Prange A. J., Bissette G.: Thyrotropin-releasing hormone (TRH) and its beta-alanine analogue: potentiation of the anticonvulsant potency of pentobarbital in mice. Commun. Psychopharmacol., 1975, 1, 305-317.
16. Ogawa N., Hirose Y., Mori A., Kajita S., Sato M.: Involvement of thyrotropin-releasing hormone (TRH) neural system of the brain in pentylenetetrazol-induced seizures. Regul. Peptides, 1985, 12, 249-256.
17. Ogawa T., Moriwake T., Morimoto K., Sato M., Otsuki S.: The effect of a novel TRH analog (DN-1417) on postictal seizure inhibition in amygdaloid kindled cats. No. To. Shinkei, 1984, 36, 951-955.
18. Oliver C., Eskay R. L., Ben-Jonathan N., Porter J. C.: Distribution and concentration of TRH in the rat brain. Endocrinology, 1974, 96, 540-546.
19. Osonoe K., Mori N., Ohno E., Kumashiro H.: Effects of thyrotropin-releasing hormone (TRH) on status epilepticus in rats. No. To. Shinkei, 1991, 43, 247-254.
20. Przewłocka B., Lason W., Machelska H., Van Luijtelaar G., Coenen A., Przewlocki R.: Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats. Neurosci. Lett., 1995, 186, 131-134.
21. Przewłocka B., Stala L., Lasoń W., Przewłocki R.: The effect of various opiate receptor agonists on the seizure threshold in the rat. Is dynorphin an endogenous anticonvulsant? Life Sci., 1983, 33 Suppl. 1, 595-598.
22. Rothman R. B.: A rewiev of the role of anti-opioid peptides in morphine tolerance and dependence. Synapse, 1992, 12, 129-138.
23. Sakai S., Baba H., Sato M., Wada J. A.: Effect of DN-1417 on photosensitivity and cortically kindled seizure in Senegalese baboons, Papio papio. Epilepsia, 1991, 32, 16-21.
24. Takahashi H., Nakazawa T., Kanazawa G., Kaneko K., Ohtsuka C.: A case of intractable epilepsy with pachygyria: the effect of TRH-T treatment. No. To. Hattatsu, 1993, 25, 465-470.
25. Van Luijtelaar E. L. J. M., Coenen A. M. L.: Two types of electrocortical paroxysms in an inbred strain of rats. Neurosci. Lett., 1986, 70, 393-397.
26. Van Luijtelaar E. L. J. M., Coenen A. M. L.: The WAG/Rij model for generalized absence seizures. In: Advances in Epileptology. Eds. Manelis E. B., Loeber J. N., Dreifuss F. E., Raven Press, New York, 1989, 17, 78-83.
27. Vergnes M., Marescaux C., Depaulis A.: Mapping of spontaneous spike and wave discharges in Wistar rats with genetic generalized non-convulsive epilepsy. Brain Res., 1990, 523, 87-91.
28. Winokur A., Utiger R. D.: Thyrotropin releasing hormone: regional distribution in rat brain. Science, 1974, 185, 265-266.
29. Yamashita K., Mori A., Otsuki S.: Changes in brain thyrotropin-releasing hormone (TRH) of seizure-prone E1 mice. Exp. Neurol., 1990, 108, 71-75.
30. Yatsugi S., Yamamoto M.: Anticonvulsive properties of YM-14673, a new TRH analogue, in amygdaloid-kindled rats. Pharmacol. Biochem. Behav., 1991, 38, 669-672.
31. Yoshida M., Izumi K., Nakanishi T.: Effects of thyrotropin releasing hormone (TRH) on glutamate-induced seizures in rats. Tohoku J. Exp. Med., 1987, 152, 311-317.